Who are Disc Medicine's investors?

Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed, 5AM Ventures, Alexandria and 6 more.

Disc Medicine

NASDAQ: IRON

170 employees on LinkedIn · 15 known investors

Find your way into Disc Medicine

Paths you didn't know you had: your email and LinkedIn already hold routes to the Disc Medicine team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.

Biotech Healthtech

Founders & leadership

John QuiselChief Executive Officer

Jean FranchiChief Financial OfficerJean Franchi is Chief Financial Officer of Disc Medicine and has over 30 years of experience in life sciences finance and operations across biotech, diagnostics, and medical device companies at stages ranging from pre-clinical to commercial. He holds board positions at multiple life sciences companies including Biodesix, Flamingo Therapeutics, and VectorY Therapeutics.

Jonathan YuChief Operating Officer

Will SavageChief Medical Officer

Pamela StephensonChief Commercial OfficerShe has held leadership roles in biotech and pharmaceutical companies, with background in product launches and brand marketing.

Steve CafféChief Regulatory Officer

Rahul Rajan KaushikChief Technical OfficerRahul Rajan Kaushik holds a Ph.D. from Stanford University in chemistry and cell biology, and brings over 20 years of experience in pharmaceutical process development, analytical development, manufacturing, and commercialization across antibodies, small molecules, and protein conjugates. At Disc Medicine, he serves as Chief Technical Officer leading cross-functional teams through regulatory submissions and commercial launch.

Rahul KharaChief Legal Officer

Lisa Amaya PriceChief Human Resources OfficerShe brings over 20 years of human resources experience across multiple fast-growth industries.

Hua YangChief Early Development Officer

Investors · 15

Access Biotechnologylisted by Access BiotechnologyNew York

How we know: Access Biotechnology's portfolio page · globalgenes.org · Not right? Tell us

Atlas Venturelisted by Atlas VentureCambridge · $500K – $1M

How we know: Atlas Venture's portfolio page · globalgenes.org · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston

How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · a partner's Signal profile · globalgenes.org · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

5AM VenturesreportedSan Francisco · $100K – $4M

How we know: globalgenes.org · Not right? Tell us

AlexandriareportedPasadena

How we know: globalgenes.org · Not right? Tell us

Arix BiosciencereportedLondon

How we know: globalgenes.org · Not right? Tell us

Janus Henderson InvestorsreportedLondon

How we know: globalgenes.org · Not right? Tell us

JMI EquityreportedSan Diego · $25M – $250M

How we know: a partner's Signal profile · Not right? Tell us

Novo HoldingsreportedHellerup · $1.1M – $54M

How we know: globalgenes.org · Not right? Tell us

Rock Springs CapitalreportedBaltimore

How we know: globalgenes.org · Not right? Tell us

Willett AdvisorsreportedNew York

How we know: globalgenes.org · Not right? Tell us

Also in the syndicate · 1

Nantahala Capital Management

Funding

SEC filings, press & company announcements

Undisclosed amountseries BSep 2021
OrbiMed (lead), 5AM Ventures, Access Biotechnology, Alexandria Venture Investments, Arix Bioscience, Atlas Venture, Janus Henderson Investors, Nantahala Capital Management, Novo Holdings, Rock Springs Capital, Willett Advisors
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Disc Medicine went on to found or lead other companies.

Kevin BittermanBoard Of DirectorsFounded Editas Medicine Nadim AhmedBoard DirectorFounded Cullinan Therapeutics

Related companies · 3

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies working in the same space as Disc Medicine.

Frequently asked questions

What does Disc Medicine do?: Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.
Who are Disc Medicine's investors?: Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed, 5AM Ventures, Alexandria and 6 more.